LIQUID DISPENSER AND FLEXIBLE BAG THEREFOR
    1.
    发明申请
    LIQUID DISPENSER AND FLEXIBLE BAG THEREFOR 审中-公开
    液体分配器和柔性袋

    公开(公告)号:WO2004067439A3

    公开(公告)日:2004-12-09

    申请号:PCT/US0339243

    申请日:2003-12-10

    Applicant: BAXTER INT

    Abstract: A liquid dispenser uses (1) a flexible bag (9) having expansible and collapsible cells (61, 65, 69, 73, 77). A rigid manifold (95) is provided in the bag to keep passages open in use and to isolate one of the cells from the remaining cells. In one application, a concentrated drink mix may be held in a reservoir (61, 65)and diluted within other cells (73, 77) in the bag for dispensing to a cup (c) or the like. A valve system allows for the particulates in the liquid without compromising the function of the valve.

    Abstract translation: 液体分配器使用(1)具有可膨胀和可折叠单元(61,65,69,73,77)的柔性袋(9)。 在袋中设置刚性歧管(95)以在使用中保持通道开放并将其中一个电池与其余电池隔离。 在一个应用中,浓缩饮料混合物可以保持在储存器(61,65)中并在袋中的其它细胞(73,77)内稀释以分配到杯子(c)等中。 阀系统允许液体中的微粒而不损害阀的功能。

    CONTROLLED ADMINISTRATION OF BENEFICIAL AGENT TO BLOOD.
    3.
    发明公开
    CONTROLLED ADMINISTRATION OF BENEFICIAL AGENT TO BLOOD. 失效
    GESTEUERTE VERABREICHUNG EINES HEILMITTELS一个BLUT。

    公开(公告)号:EP0341291A4

    公开(公告)日:1990-07-03

    申请号:EP89900112

    申请日:1988-11-08

    Applicant: BAXTER INT

    CPC classification number: A61M1/3672 A61M1/3673

    Abstract: As one administers blood through a conduit (10) into a container (12), the blood is passed in the conduit across the supply of beneficial agent (18), such as anticoagulant, to cause a controlled amount of beneficial agent to enter the passing blood in a manner that is substantially uniform overtime. The beneficial agent (18) is typically in dry form until it enters into contact with the blood. Accordingly, no substantial portion of the blood is exposed to a significantly higher concentration of the beneficial agent than other portions of the blood.

    Abstract translation: 当通过导管(10)将血液施用到容器(12)中时,血液在管道中通过有益剂(18)的供应,例如抗凝血剂,以引起受控量的有益剂进入通过 血液的加班时间基本一致。 有益剂(18)通常是干燥形式,直到其与血液接触。 因此,与血液的其他部分相比,没有相当一部分血液暴露于有益剂量的明显更高的浓度。

    7.
    发明专利
    未知

    公开(公告)号:DE2858828C2

    公开(公告)日:1993-12-02

    申请号:DE2858828

    申请日:1978-08-11

    Applicant: BAXTER INT

    Abstract: A blood component separating device comprises a centrifuge bowl adapted for rotation about its axis in a centrifuge. The bowl defines an outer arcuate wall plus an inner circumferential wall, spaced from the outer wall, to define a arcuate slot adapted for receiving blood components. Access tubing is adapted for communication with the slot. Preferably, an elongated, flexible, collapsible inner liner is provided in the slot. Individual access tubing also may communicate with an elongated container interior between the ends of the elongated, collapsible container. Furthermore, a portion of the slot may define the shape of an outwardly extending spiral, to provide an increasing gravitational field upon fluids therein as the fluid moves along the slot.

    8.
    发明专利
    未知

    公开(公告)号:DE69815481T2

    公开(公告)日:2004-05-06

    申请号:DE69815481

    申请日:1998-12-16

    Applicant: BAXTER INT

    Abstract: A resealable access site (10) is provided for allowing a cannula (18) multiple accesses to an internal cavity (35) defined by a container (12). The access site (10) includes a first conduit (28) defining a passageway (29) forming a fluid path to the cavity within the container. Sealingly attached to the conduit (28) is a housing (26) with a lower portion (26a) and a lower flange (68) attached to a lower end of the lower portion and extending radially inward from the lower portion. A septum (24) is disposed and compressed within the lower portion, with the septum defining an opening (46) extending upward through at least a portion of the septum. The opening (46) is sized for insertion of the cannula (18) through the septum (24) with the septum sealing about the exterior of the cannula. The septum (24) is maintained in the housing by the support provided by the opposing flange (68) and conduit (28).

    9.
    发明专利
    未知

    公开(公告)号:DE69815481D1

    公开(公告)日:2003-07-17

    申请号:DE69815481

    申请日:1998-12-16

    Applicant: BAXTER INT

    Abstract: A resealable access site (10) is provided for allowing a cannula (18) multiple accesses to an internal cavity (35) defined by a container (12). The access site (10) includes a first conduit (28) defining a passageway (29) forming a fluid path to the cavity within the container. Sealingly attached to the conduit (28) is a housing (26) with a lower portion (26a) and a lower flange (68) attached to a lower end of the lower portion and extending radially inward from the lower portion. A septum (24) is disposed and compressed within the lower portion, with the septum defining an opening (46) extending upward through at least a portion of the septum. The opening (46) is sized for insertion of the cannula (18) through the septum (24) with the septum sealing about the exterior of the cannula. The septum (24) is maintained in the housing by the support provided by the opposing flange (68) and conduit (28).

    CONTROLLED ADMINISTRATION OF BENEFICIAL AGENT TO BLOOD

    公开(公告)号:CA1339088C

    公开(公告)日:1997-07-29

    申请号:CA582994

    申请日:1988-11-14

    Applicant: BAXTER INT

    Abstract: As one administers blood through a conduit into a container, the blood is passed in the conduit across the supply of beneficial agent, such as anticoagulant, to cause a controlled amount of beneficial agent to enter the passing blood in a manner that is substantially uniform over time. The beneficial agent is typically in dry form until it enters into contact with the blood. Accordingly, no substantial portion of the blood is exposed to a significantly higher concentration of the beneficial agent than other portions of the blood.

Patent Agency Ranking